Anderson Jenny Louise, Fromentin Rémi, Corbelli Giulio Maria, Østergaard Lars, Ross Anna Laura
1 The Peter Doherty Institute, The University of Melbourne , Melbourne, Australia .
AIDS Res Hum Retroviruses. 2015 Jan;31(1):36-44. doi: 10.1089/AID.2014.0236.
Biomedical research has led to profound advances in the treatment of HIV infection. Combination antiretroviral therapy (ART) now provides the means to readily control viral infection, and people living with HIV who receive timely and effective ART can expect to benefit from a life expectancy comparable to uninfected individuals. Nevertheless, despite effective treatment, ART does not fully restore the immune system and importantly HIV persists indefinitely in latent reservoirs, resulting in the need for life-long treatment. The challenges and limits of life-long treatment have spurred significant scientific interest and global investment into research towards an HIV cure. The International AIDS Society (IAS) 2014 Towards an HIV cure symposium brought together researchers and community to discuss the most recent advances in our understanding of latency and HIV reservoirs, and the clinical approaches towards an HIV cure under current investigation. This report summarizes and reviews some of the major findings discussed during the symposium.
生物医学研究已在HIV感染治疗方面取得了深远进展。联合抗逆转录病毒疗法（ART）如今提供了轻松控制病毒感染的手段，接受及时有效ART治疗的HIV感染者有望获得与未感染者相当的预期寿命。然而，尽管治疗有效，但ART并不能完全恢复免疫系统，重要的是HIV会在潜伏库中无限期持续存在，这就导致需要终身治疗。终身治疗的挑战和局限激发了科学界的浓厚兴趣以及全球对治愈HIV研究的投资。国际艾滋病学会（IAS）2014年关于治愈HIV的研讨会汇聚了研究人员和社会各界，以讨论我们对潜伏期和HIV潜伏库理解的最新进展，以及目前正在研究的治愈HIV的临床方法。本报告总结并回顾了研讨会上讨论的一些主要发现。
